UNICA IRIS Institutional Research Information System

PERRA, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 192.988
NA - Nord America 4.902
AS - Asia 966
OC - Oceania 19
SA - Sud America 13
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 198.901
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 191.619
US - Stati Uniti d'America 4.861
CN - Cina 553
SE - Svezia 413
UA - Ucraina 310
DE - Germania 252
SG - Singapore 185
GB - Regno Unito 117
FI - Finlandia 111
VN - Vietnam 46
CA - Canada 40
FR - Francia 38
TR - Turchia 38
BE - Belgio 33
KR - Corea 31
RU - Federazione Russa 20
AU - Australia 19
IR - Iran 18
ID - Indonesia 16
NL - Olanda 16
HK - Hong Kong 14
IN - India 14
ES - Italia 10
IE - Irlanda 10
MY - Malesia 9
JP - Giappone 8
LT - Lituania 7
TH - Thailandia 7
ZA - Sudafrica 7
IL - Israele 6
AT - Austria 5
BR - Brasile 5
TW - Taiwan 5
CH - Svizzera 4
CZ - Repubblica Ceca 4
EU - Europa 4
MT - Malta 4
AR - Argentina 3
BD - Bangladesh 3
CO - Colombia 3
DK - Danimarca 3
AE - Emirati Arabi Uniti 2
IQ - Iraq 2
MK - Macedonia 2
PE - Perù 2
PT - Portogallo 2
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
JO - Giordania 1
LK - Sri Lanka 1
MV - Maldive 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
Totale 198.901
Salva come PNG Salva come JPEG
Città #
Cagliari 187.535
Uta 3.551
Fairfield 611
Chandler 412
Woodbridge 395
Ashburn 358
Nyköping 331
Houston 324
Boardman 294
Ann Arbor 261
Wilmington 243
Seattle 202
Cambridge 196
Jacksonville 157
Dearborn 156
Singapore 112
Shanghai 106
Santa Clara 100
Beijing 77
Helsinki 63
Nanjing 60
New York 50
Boston 46
Dong Ket 46
Redwood City 43
Rome 43
San Diego 43
Los Angeles 42
Milan 35
Guangzhou 34
Brussels 33
Kocaeli 29
San Mateo 29
Seoul 28
Toronto 28
Falls Church 26
Nanchang 25
London 24
Jiaxing 21
Shenyang 20
Mountain View 19
Minneapolis 16
Augusta 14
Jinan 14
Leawood 14
Washington 14
Changsha 13
Hong Kong 13
Frankfurt am Main 12
Munich 12
Norwalk 12
Shenzhen 12
Bari 11
Sassari 11
Verona 11
Atlanta 10
Hebei 10
Wuhan 10
Orange 9
Paris 9
Zhengzhou 9
Olbia 8
Ardabil 7
Bogazici 7
Dublin 7
Millbury 7
Pisa 7
Auburn Hills 6
Detroit 6
Hefei 6
Milwaukee 6
Monserrato 6
Ningbo 6
Phoenix 6
Piscataway 6
Pune 6
Bologna 5
Columbus 5
Florence 5
La Spezia 5
Madrid 5
Ploaghe 5
Porto Torres 5
Quartu Sant'elena 5
Selargius 5
Taizhou 5
Vienna 5
Amsterdam 4
Brno 4
Chiswick 4
Genoa 4
Grassano 4
Luras 4
Melita 4
Pretoria 4
Settimo Torinese 4
Tianjin 4
Turin 4
Barrali 3
Bogotá 3
Totale 196.646
Salva come PNG Salva come JPEG
Nome #
null 13.191
Thyroid hormone receptor ligands induce regression of rat preneoplastic liver lesions causing their reversion to a differentiated phenotype 5.905
α2A adrenergic receptors highly expressed in mesoprefrontal dopamine neurons 5.651
Expression of c-jun is not mandatory for mouse hepatocyte proliferation induced by two nuclear receptor ligands: TCPOBOP and T3 4.859
Statistical health monitoring applied to a metabolomic study of experimental hepatocarcinogenesis: an alternative approach to supervised methods for the identification of false positives 4.145
Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice 4.105
YAP activation is an early event and a potential therapeutic target in liver cancer development 3.899
Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats 3.805
Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats 3.729
TRbeta is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells 3.634
Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis 3.580
Alpha-lipoic acid promotes the growth of rat hepatic preneoplastic lesions in the choline deficient model 3.579
Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis 3.541
Emerging role of the pentose phosphate pathway in hepatocellular carcinoma 3.495
Global gene expression profile of normal and regenerating liver in young and old mice 3.449
Transcription profiling by array of mouse liver from TCPOBOP treated wild type and c-jun conditional knockout animals. 3.352
Induction of hepatocyte proliferation by retinoic acid 3.208
Gastrointestinal Coronavirus disease 2019: epidemiology, clinical features, pathogenesis, prevention, and management 3.137
MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC). 3.051
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis 3.038
Potential utility of xenobiotic mitogens in the context of liver regeneration in the elderly and living-related transplantation 3.012
Induction of autophagy promotes the growth of early preneoplastic rat liver nodules 2.950
THYROID HORMONE RECEPTORS DOWNREGULATION IS AN EARLY EVENT AND IS MAINTAINED ALLACROSS THE STEP-BY-STEP PROCESS OF HEPATOCARCINOGENESIS 2.872
Wnt/beta-catenin pathway is activated by thyroid hormone and is required for its hepatomitogenic activity 2.856
The thyromimetic KB2115 (Eprotirome) induces rat hepatocyte proliferation 2.846
The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival 2.816
ALFA-LIPOIC ACID ENHANCES CHOLINE DEFICIENT DIET-INDUCED FATTY LIVER AND STEATOHEPATITIS, AND PROMOTES THE GROWTH OF PRENEOPLASTIC LESIONS IN RAT LIVER. POSTER EASL 2.790
Reply to: "YAP in tumorigenesis: Friend or foe?" 2.692
Thyroid hormone receptors downregulation is an early event and is maintained all across the step-by-step process of hepatocarcinogenesis. 2.689
NRF2 mutations are frequent in early rat preneoplastic hepatic lesions and in human hepatocellular carcinomas positive for the stem/progenitor cell marker KRT-19 2.677
A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis 2.627
Progenitor-derived hepatocellular carcinoma model in the rat 2.606
T3/TRs axis in hepatocellular carcinoma: new concepts for an old pair 2.548
Timed regulation of P-element-induced wimpy testis-interacting RNA expression during rat liver regeneration 2.547
High frequency of β-catenin mutations in mouse hepatocellular carcinomas induced by a nongenotoxic constitutive androstane receptor agonist 2.539
IMPACT OF KILLER-CELL IMMUNOGLOBULIN-LIKE RECEPTORS ON PROGRESSION OF HEPATOCELLULAR CARCINOMA 2.447
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression 2.435
Thyroid hormone induces cyclin D1 nuclear translocation and DNA synthesis in adult rat cardiomyocytes 2.431
null 2.399
Induction of pancreatic acinar cell proliferation by thyroid hormone 2.386
Potential utility of xenobiotic mitogens in the context of liver regeneration in the elderly and living-related transplantation 2.350
Genetic inactivation of Nrf2 prevents clonal expansion of initiated cells in a nutritional model of rat hepatocarcinogenesis 2.316
Role of natural killercells receptors on the development and progression of hepatocellularcarcinoma 2.302
Ciprofibrate and triiodothyronine do not suppress in vivo induction of placental glutathione S-transferase expression in rat hepatocytes 2.301
Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene 2.299
Thyroid hormones, thyromimetics and their metabolites in the treatment of liver disease 2.235
Entropy of human leukocyte antigen and killer-cell immunoglobulin-like receptor systems in immune-mediated disorders: A pilot study on multiple sclerosis 2.050
Cell proliferation induced by 3,3',5 triiodo L thyronine is associated with a reduction in the number of preneoplastic hepatic lesions 2.018
Cytokeratin-19, a predictive marker and an early determinant of progenitor-derived hepatocellular carcinoma 1.903
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience 1.862
Is the Inversion in the Trend of the Lethality of the COVID-19 in the Two Hemispheres due to the Difference in Seasons and Weather? 1.799
Different effects of the liver mitogens triiodo-thyronine and ciprofibrate on the development of rat hepatocellular carcinoma 1.708
Cell proliferation induced by triiodothyronine in rat liver is associated with nodule regression and reduction of hepatocellular carcinomas 1.680
Animal models: A useful tool to unveil metabolic changes in hepatocellular carcinoma 1.532
The Effect of Exposure to SARS-CoV-2 Vaccination and Infection on Humoral and Cellular Immunity in a Cohort of Patients with Immune-Mediated Diseases: A Pilot Study 1.519
Early metabolic changes in a liver carcinogenesis model 1.409
Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis 1.350
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection 1.290
Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination 1.193
Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination 1.158
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming 1.111
Early Metabolic Changes in preneoplastc nodules of the liver 1.085
Hepatic stellate cell: a star cell in the liver 1.028
A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited From Neanderthals in the Sardinian Population 903
Non-Invasive Detection of a De Novo Frameshift Variant of STAG2 in a Female Fetus: Escape Genes Influence the Manifestation of X-Linked Diseases in Females 884
A review of the main genetic factors influencing the course of COVID-19 in Sardinia: the role of human leukocyte antigen-G 870
Potential role of two novel agonists of thyroid hormone receptor-β on liver regeneration 837
Tg68, a novel thyroid hormone receptor‐β agonist for the treatment of NAFLD 833
Evaluation of Antibody Response to Heterologous Prime-Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study 784
Amoxicillina-acido clavulanico ed anticoagulanti orali:un’associazione potenzialmente pericolosa 742
The density of hepatic autonomic innervation differs between compensatory and direct hyperplasia rat models 733
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC 730
COVID-19 Vaccine Hesitancy among Italian Healthcare Workers: Latent Profiles and Their Relationships to Predictors and Outcome 705
Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis 692
Decision trees for early prediction of inadequate immune response to coronavirus infections: a pilot study on COVID-19 664
The double-sided of human leukocyte antigen-G molecules in type 1 autoimmune hepatitis 661
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 652
Inhibitory effect of thyroid hormone (T3) on the development of rat hepatocellular carcinoma. POSTER 577
Delta-globin gene expression improves sickle cell disease in a humanised mouse model 560
Humoral responses to wild type and ancient BA.1 SARS-CoV-2 variant after heterologous priming vaccination with ChAdOx1 nCoV-19 and BNT162b2 booster dose 560
Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity 545
mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma 539
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 502
Morphological alterations of the lung in the Sickle Cell Trait 477
Triiodothyronine stimulates hepatocyte proliferation in two models of impaired liver regeneration 470
Diverse MicroRNAs-mRNA networks regulate the priming phase of mouse liver regeneration and of direct hyperplasia 392
Alpha lipoic acid promotes preneoplastic growth in rat liver. POSTER 23° Meeting of German Association for the Study of Liver (GASL), Gottingen 377
THYROID HORMONE INHIBITS HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT BY INTERFERING WITH THE METABOLIC PROFILE OF CANCER CELLS 370
Analysis of pathological findings in a humanized murine model of sickle cell anemia 364
Multi-Organ Morphological Findings in a Humanized Murine Model of Sickle Cell Trait 362
Evaluation of humoral and cellular response to third dose of BNT162b2 mRNA COVID-19 vaccine in patients treated with B-cell depleting therapy 352
Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma 338
Impact of Exposure to Vaccination and Infection on Cellular and Antibody Response to SARS-CoV-2 in CVID Patients Through COVID-19 Pandemic 332
Editorial: Targeting Thyroid Hormone-Dependent Pathways in Proliferative and Degenerative Disorders 314
Novel thyroid hormone receptor beta agonist TG68 safely induces hepatic fat loss reduction in a NASH mouse model 314
Morphological investigation of endothelial and sub-endothelial alterations associated with sickle cell trait in a mouse model 314
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 305
α-Synuclein seeding activity in duodenum biopsies from Parkinson's disease patients 303
Electron microscopy investigation of the Townes mouse spleen: an example of Translational Anatomy 287
Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis 233
Totale 198.893
Salva come PNG Salva come JPEG
Categoria #
all - tutte 230.366
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 230.366
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202017.148 0 0 0 0 0 7.914 4.363 1.100 617 842 718 1.594
2020/202141.747 1.302 1.782 1.610 11.592 7.602 4.664 2.908 2.740 1.336 2.419 2.441 1.351
2021/202210.543 1.481 750 419 752 937 661 455 434 1.189 1.105 1.233 1.127
2022/202316.318 1.073 2.121 2.240 1.383 1.260 1.700 902 940 1.116 1.236 1.499 848
2023/202416.202 1.026 678 893 923 1.442 2.416 2.610 1.407 687 990 1.364 1.766
2024/202533.090 11.399 12.112 3.543 3.185 1.523 1.328 0 0 0 0 0 0
Totale 199.229